from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1226c/-

LFCtreatmentdescriptionclass of inhibitor

0.319

Amikacinug/mL Amikacintranslation

1.511

Cap5-10ug/mL Capreomycintranslation

0.000

Rox10-50 ug/mL Roxithromycintranslation

-0.008

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.712

Rif0.2-5ug/mL Rifampicintranscription

0.000

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.494

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.211

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.348

CPZ10-50 ug/mL Chlorpromazinerespiration

0.109

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.007

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.009

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.230

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.596

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.115

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.443

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.697

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.664

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.966

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.637

KCN5-20 ug/mL Potassium cyaniderespiration

-0.315

NaN30.2-2 mM Sodium aziderespiration

-0.882

Nigericin50 uM Nigericinrespiration

0.380

TRC10-150 ug/mL Triclosanrespiration

0.197

TRZ10-25 ug/mL Thioridazinerespiration

-1.763

Valinomycin0.5-10 uM Valinomycinrespiration

-1.007

ZnSO42 mM ZnSO4respiration

-0.951

menadione6-10 ug/mL Menadionerespiration

-0.712

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.987

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.300

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.762

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.550

NRP_1Non-replicating persistence stage 1dosRassociated

0.007

Amp0.2mg/mL AmpicillincellWall

0.171

Cephalexin20-100 ug/mL CephalexincellWall

2.031

Cerulenin0.32-5 ug/mL CerulenincellWall

0.959

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.364

EMB10-20 ug/mL EthambutolcellWall

0.163

Eta12-40 ug/mL EthionamidecellWall

-0.102

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.135

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.686

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.843

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.310

BZA0.12 mg/mL BenzamidearomaticAmides

-0.119

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.311

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.752

H2O24 mM hydrogen peroxideDNAdamaging

4.422

Levo10 ug/mL LevofloxacinDNAdamaging

-0.030

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.378

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.285

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.019

UVUV-irradiationDNAdamaging

0.466

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.198

Antimycin12.5-50 ug/mL Antimycin A?

-1.162

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.335

PA_110-50 ug/mL Antitubercular compound PA-1?

0.465

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.252

PA8240.2-2 ug/mL PA-824?

-0.467

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.480

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.983

Verapamil50 uM Verapamil?

-1.107

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.252

methoxatin10-20 ug/mL Methoxatin?